SI-BONE Appoints Anshul Maheshwari as Chief Financial Officer and Announces the Addition of Helen Loh and Laura Francis to the Board of Directors
SANTA CLARA, Calif., April 19, 2021 (GLOBE NEWSWIRE) -- SI-BONE, Inc., (Nasdaq: SIBN), a Silicon Valley-based medical device company dedicated to solving musculoskeletal disorders of the
sacropelvic anatomy, today announced the appointment of Anshul Maheshwari as the company’s Chief Financial Officer effective April 20, 2021, and the addition of Helen Loh and Laura Francis to its
Board of Directors effective April 18, 2021. The appointment of Mr. Maheshwari completes the recently announced senior leadership transition which includes Laura Francis succeeding Jeff Dunn as
Chief Executive Officer, and Tony Recupero becoming President, Commercial Operations. Jeff Dunn will remain with the company as Executive Chairman.
“Anshul is an experienced finance executive with an impressive record of building high performance finance teams to scale in global, high growth organizations,” said Laura Francis, Chief Executive Officer. “His industry expertise and relationships within the investment community will strengthen our leadership team as we execute our strategy to invest in future growth.”
Mr. Maheshwari joins SI-BONE with over 15 years of experience in corporate finance, banking, treasury, and strategy. Most recently, Mr. Maheshwari served as Vice President of Finance, Investor Relations and Treasurer for Varian Medical Systems, a leading cancer care platform, where he held roles of increasing responsibilities since 2018. Prior to joining Varian Medical Systems, Mr. Maheshwari was Assistant Treasurer for Bechtel Corporation, a leading engineering and construction company. Prior to that, Mr. Maheshwari spent majority of his career at Bank of America in corporate and investment banking.
Mr. Maheshwari stated, “I am excited to be joining SI-BONE at such a pivotal time. I look forward to partnering with the entire SI-BONE team to continue to execute on our growth and value creation strategy, deliver innovative and differentiated products to surgeons and improve patients’ lives.”
In addition to Mr. Maheshwari’s appointment as Chief Financial Officer, SI-BONE announced the election of Helen Loh to its board of directors. Ms. Loh joins SI-BONE with over 25 years of experience in brand and growth marketing at both Fortune 500 and early-stage technology companies. Currently, Ms. Loh is the Senior Vice President of Digital, Product, and Client Marketing at Charles Schwab, where she has held roles of increasing responsibilities since 2004. Ms. Loh holds a BS in industrial engineering and MBA from Stanford University.